Clinical Trials Directory

Trials / Completed

CompletedNCT06382376

The Effect of Analgesia Methods Applied in Gynecological Cancer Surgeries on Postoperative Analgesia

Four-quadrant Transversus Abdominis Plane Block Versus Intrathecal Morphine in Gynecological Cancer Surgeries: a Single-center Retrospective Study.

Status
Completed
Phase
Study type
Observational
Enrollment
71 (actual)
Sponsor
Bakirkoy Dr. Sadi Konuk Research and Training Hospital · Other Government
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to compare the effectiveness of intrathecal morphine and four-quadrant transversus abdominis plane block applied for postoperative analgesia in gynecological cancer surgeries. The key question(s) it aims to answer are: \[Is intrathecal morphine more effective in postoperative analgesia?\] Patients who underwent gynecological cancer surgery were examined retrospectively. The investigators evaluated the effect of intrathecal morphine and four-quadrant transversus abdominis plane block applied for postoperative analgesia on pain scores and postoperative opioid use.

Detailed description

Our study was designed retrospectively. The investigators evaluated analgesia methods in patients who underwent laparoscopic or open surgery due to gynecological cancer between June 2023 and December 2023. The investigators evaluated the effect of intrathecal morphine and four-quadrant transversus abdominis plane block on postoperative analgesia and opioid use. Group 1: Intrathecal morphine administered group Group 2: Four quadrant transversus abdominis plane block applied group

Conditions

Interventions

TypeNameDescription
PROCEDUREIntrathecal morphine administered group, Four quadrant transversus abdominis plane block applied groupIntrathecal morphine administered group and Four quadrant transversus abdominis plane block applied group

Timeline

Start date
2023-06-01
Primary completion
2023-12-01
Completion
2024-03-01
First posted
2024-04-24
Last updated
2024-04-26

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06382376. Inclusion in this directory is not an endorsement.